LIGAND PHARMACEUTICALS INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 of $3.88 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 · last filed 2019-02-28
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for the quarter ending 2015-12-31 was -$765.00K.
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for the quarter ending 2015-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2018 was $3.88M, a 1838.50% increase from fiscal 2017.
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2017 was $200.00K, a 33.33% decline from fiscal 2016.
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2016 was $300.00K, a 93.73% decline from fiscal 2015.
- LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2015 was $4.78M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 12 month |
|---|---|---|---|---|
| 2018-12-31 | $3.88M 10-K · filed 2019-02-28 | |||
| 2017-12-31 | $200.00K 10-K · filed 2018-03-01 | |||
| 2016-12-31 | $300.00K 10-K · filed 2017-02-28 | |||
| 2015-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | -$765.00K derived: sum of 2 quarters · filed 2016-11-14 | $4.78M 10-K · filed 2016-11-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.55M 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $5.55M 10-Q · filed 2015-08-05 |